Bio safety Testing Market By Product (Reagents and Kits, Instruments, and Other Products), By Test (Sterility Tests, Cell Line Authentication and Characterization Tests, Bioburden Tests, Endotoxin Tests, Adventitious Agent Detection Tests, and Other Tests), By Application (Vaccines and Therapeutics, Cellular and Gene Therapy, Blood and Blood-based Therapy, and Other Applications), and By Region - Trends, Analysis, and Forecast till 2029

Report Code: PMI427820 | Publish Date: May 2023 | No. of Pages: 180

Global Bio Safety Testing Market Companies

  • Avance Biosciences
  • Cytovance Biologics
  • Thermo Fisher Scientific
  • Merck KGaA
  • Eurofins Scientific
  • Lonza
  • Promega Corporation
  • Toxikon
  • WuXi AppTec.

Recent News:

  • In December 2022, WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has launched a new Biosafety Testing Center located in Lin-gang Special Area of Shanghai. This is the second centre in WuXi Biologics' global network for third-party biologics biosafety testing services and the company's tenth operational location in China.